Zsofia Miskolczi

Zsofia Miskolczi is a highly skilled scientist with extensive experience in cancer biology, currently serving as a Senior Scientist at Adaptimmune since September 2021, where the focus is on developing and running pre-clinical packages for TCR T cell product safety and efficacy. Prior to this role, Zsofia worked at Oxford Biomedica, enhancing lentiviral vectors for gene therapy, and at PsiOxus Therapeutics Ltd, contributing to the development of novel oncolytic viruses. Zsofia's academic background includes a PhD in Oncology and Cancer Biology from The University of Manchester, where research identified a novel mechanosignalling mechanism influencing melanoma progression, as well as a Bachelor’s degree in Molecular Biology from the same institution.